You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API nitazoxanide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing nitazoxanide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
LUPIN PHARMACEUTICALS INC ALINIA nitazoxanide 27437-106 ANHYDROUS CITRIC ACID
LUPIN PHARMACEUTICALS INC ALINIA nitazoxanide 27437-106 CARBOXYMETHYLCELLULOSE SODIUM
LUPIN PHARMACEUTICALS INC ALINIA nitazoxanide 27437-106 CELLULOSE, MICROCRYSTALLINE
LUPIN PHARMACEUTICALS INC ALINIA nitazoxanide 27437-106 FD&C RED NO. 40
LUPIN PHARMACEUTICALS INC ALINIA nitazoxanide 27437-106 MALTODEXTRIN
LUPIN PHARMACEUTICALS INC ALINIA nitazoxanide 27437-106 MODIFIED CORN STARCH
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing nitazoxanide

Company Ingredient NDC Excipient
Rising Pharmaceuticals Inc nitazoxanide 64980-526 HYPROMELLOSE 2910
Rising Pharmaceuticals Inc nitazoxanide 64980-526 MAGNESIUM STEARATE
Rising Pharmaceuticals Inc nitazoxanide 64980-526 SODIUM STARCH GLYCOLATE TYPE A CORN
Rising Pharmaceuticals Inc nitazoxanide 64980-526 STARCH, CORN
Rising Pharmaceuticals Inc nitazoxanide 64980-526 TALC
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for nitazoxanide

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MODIFIED CORN STARCH

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group